10 Stocks to Buy Now According to Leonard A. Potter's Wildcat Capital Management
In this article, we discuss 10 stocks to buy now according to Leonard A. Potter's Wildcat Capital Management.
Allogene Therapeutics Inc. (ALLO)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
Hedge Fund and Insider Trading News: Michael Platt, Chris Hohn, Bill Ackman, Cathie Wood, Allogene Therapeutics Inc (ALLO), and More
Michael Platt’s wealth swelled even further last year as the billionaire continues to outperform most hedge funds with the freedom to take on riskier bets after returning clients money.
Hedge Funds Are Dumping Allogene Therapeutics, Inc. (ALLO)
In this article you are going to find out whether hedge funds think Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a good investment right now.
Should I Buy Allogene Therapeutics, Inc. (ALLO)?
In this article we will check out the progression of hedge fund sentiment towards Allogene Therapeutics, Inc. (NASDAQ:ALLO) and determine whether it is a good investment right now.
Is ALLO A Good Stock To Buy According To Hedge Funds?
In this article we are going to use hedge fund sentiment as a tool and determine whether Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a good investment right now.
Hedge Funds Are Piling Into Allogene Therapeutics, Inc. (ALLO)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Allogene Therapeutics, Inc. (ALLO): Hedge Funds Sticking Around
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Have Never Been This Bullish On Allogene Therapeutics, Inc. (ALLO)
We hate to say this but, we told you so.
Is Allogene Therapeutics, Inc. (ALLO) A Good Stock To Buy?
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Is Allogene Therapeutics, Inc. (ALLO) A Good Stock To Buy?
The financial regulations require hedge funds and wealthy investors that crossed the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
